To discuss the effects of percutaneous transhepatic cholangioscopy (PTCS) for intrahepatic and extrahepatic bile duct stones after digestive tract reconstruction.

A retrospectively analyze was made on the clinical data of twenty-six patients with intrahepatic and extrahepatic bile duct stones after digestive tract reconstruction treated by PTCS from March 2014 to June 2018 in Shifang People’s Hospital, and the clinical therapeutic effect of PTCS was evaluated.

Three cases (11.54%) were converted to open surgery after fistula rupture due to misoperation during fistula dilation. The success rate of the operation was 88.46% (23/26), and calculi were taken out once in nine cases (39.13%), twice in six cases (26.09%), three times in six cases (26.09%), four times in two cases (8.70%). The levels of indirect bilirubin (IBIL), direct bilirubin (DBIL) and total bilirubin (TBIL) of patients after operation were significantly lower than those before operation (P<0.05). The stone recurrence rate was 26.92% (7/26) after 8-41 (19.03±4.06) months of follow-up, and PTCS was performed again. No recurrence or death occurred during the follow-up period. The incidence of perioperative complications was 11.54% (3/26), one case had massive bleeding due to injury of biliary wall during operation and two cases had cholangitis after operation. The complications were improved after symptomatic treatment.

PTCS is an effective method for the treatment of intrahepatic and extrahepatic bile duct stones after digestive tract reconstruction.